Poolbeg Pharma
Business Services · United Kingdom · 11-50 Employees
View Company Info for Free
Overview
Headquarters
20 The Clubhouse Holborn, London, Englan...Phone Number
+442071831499Website
www.poolbegpharma.comRevenue
-Stock Symbol
POLBFIndustry
About Poolbeg Pharma
Is Poolbeg Pharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Poolbeg Pharma is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Poolbeg Pharma
Poolbeg Pharma, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Poolbeg Pharma launches new products
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Poolbeg Pharma has new funding data
Click to see if Poolbeg Pharma had a recent Job posting/layoffs
Check if Poolbeg Pharma has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Poolbeg Pharma recently announced quarterly report
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Poolbeg Pharma
Compare insights from companies similar to Poolbeg Pharma, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Poolbeg Pharma
Company Profile Activity
Activity Insights
Poolbeg Pharma is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Poolbeg Pharma is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Poolbeg Pharma.
Poolbeg Pharma financials insights
Gather financial insights about Poolbeg Pharma, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Stock/Share Issuance
$4.7M
Poolbeg Pharma Tech Stack
A closer look at the technologies used by Poolbeg Pharma
Poolbeg Pharma News & Media
Poolbeg Pharma PLC (POLBF) Q4 2025 Earnings Call Transcript
Poolbeg Pharma PLC (POLBF) Q4 2025 Earnings Call April 28, 2026 12:00 PM EDTCompany ParticipantsJeremy Skillington - CEO & DirectorLiam Tremble -...EnergyPathways, Scancell, Poolbeg Pharma, Santhera, Powerhouse Energy, Active Energy
EnergyPathways PLC (AIM:EPP) has launched Front End Engineering and Design for what could become the world's largest compressed air energy storage project. Pre-FEED work with Siemens Energy confirmed the project's viability, with a £15 million financing package now in place to fund the next phase. Scancell Holdings PLC (AIM:SCLP, OTC:SCNLF, FRA:SCP) has secured FDA Fast Track Designation for its lead cancer drug iSCIB1+ in advanced melanoma. Phase II trial data shows 77% progression-free survivaPoolbeg Pharma eyes partnering deals as cancer immunotherapy trial heads for summer data
Poolbeg Pharma PLC (AIM:POLB, OTC:POLBF, FRA:POLBF), the clinical-stage biopharmaceutical company, is advancing partnering discussions with multiple pharmaceutical companies as it moves towards a series of near-term clinical data readouts that management believes could catalyse a deal. Its...Poolbeg Pharma on patent grant and plans - ICYMI
Poolbeg Pharma PLC (AIM:POLB, OTC:POLBF, FRA:POLBF) earlier this week announced that it had secured its first national patent grant covering its POLB-001 programme in cancer immunotherapy-induced cytokine release syndrome (CRS), marking a significant step in the company’s expansion into...
Top Business Services Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding Poolbeg Pharma
Poolbeg Pharma is a clinical-stage biotechnology company focused on discovering and developing innovative therapies for cancer immunotherapy, metabolic diseases, and infectious diseases. The company advances proprietary drug candidates, AI-assisted drug discovery programs, and clinical research initiatives to address unmet medical needs. Its pipeli... Read More